Our comprehensive Epilepsy Program delivers world-class care for epilepsy patients with state-of-the-art techniques and treatment approaches. U of U Health is one of only a few medical centers in the ...

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...

GeneDx, a Stamford-based genomic testing firm formerly known as Sema4, said Wednesday it is launching a new program intended to increase access to exome sequencing for pediatric epilepsy patients.

A study found that the characteristics and location of epilepsy centers in the United States are associated with differences in presurgical testing for drug-0resistant epilepsy. The location and ...